skip to Main Content

Frank Boyle

Chief Executive

Frank Boyle, a successful local businessman, studied Mechanical Engineering at the Institute of Technology Sligo in the early 80’s. He is a serial entrepreneur with a proven track record in the Med-tech and Pharma Industry. Frank is a graduate of Stanford University Business School (2010) completing their Leadership for Growth program in conjunction with Enterprise Ireland. He received the Sligo Chambers of Commerce Businessperson of the year award in 2015 and is personal investor in a number of start-up Med-tech companies both in Ireland and Europe. Frank has an extensive career history including: Engineer with Steifel Laboratories, Sligo (1981), Design Engineer with Adtech Teo, Co Meath (1982), Design Engineer with Donegal International Machinery, Ballyshannon (1983), Variety of Engineering Roles with Abbott Laboratories, Ballytivnan, Sligo (1983 – 1991), Technical and General Manager with Hospicare / B Braun, Collooney, Sligo (1991 to 1995), Plant Manager and CTO with Safe Tech Medical, Korea and Sligo (1995), CEO and Managing Director with ProTek Medical, Sligo (1995 to 2016). Frank established ProTek Medical in 1995 as a custom Design, Development and Manufacturing Solution Provider to the Medical Device and Pharma Industries. ProTek was quickly established as a key player and market leader within the industry and by 2015 had over 200 employees serving 6 out of the top 20 leading Med-tech companies in the world. It had over 250 products going to 17 countries with over 60 graduates employed.
Frank successfully negotiated the acquisition of ProTek Medical in May of 2015 to the second largest privately held company in the world, Koch Industries. This has been a major achievement and secured the future development of a local business that has contributed well over €110 m into the Sligo area since 1995 by way of wages, salaries and local spending. Franks commitment to Sligo is further reinforced by substantial investment in a number of local development projects targeting innovation and job creation.
Back To Top